Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1937]

CNS involvement and prophylaxis in acute lymphoblastic leukaemia

Dr Mark Litzow - Mayo Clinic, Rochester, USA

CNS involvement and prophylaxis in acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )

Indications for allogeneic haematopoietic stem cell transplantation in adult...

Dr Mark Litzow - Mayo Clinic, Rochester, USA

Indications for allogeneic haematopoietic stem cell transplantation in adult acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )

Metabolic vulnerability in NOTCH-driven T cell acute lymphoblastic leukaemia

Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK

Metabolic vulnerability in NOTCH-driven T cell acute lymphoblastic leukaemia ( Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK )

MLL-rearranged acute lymphoblastic leukaemia

Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain

MLL-rearranged acute lymphoblastic leukaemia ( Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain )

Updates on bispecific T cell engagers (BiTEs) for the treatment of acute...

Prof Max Topp - University of Würzburg, Würzburg, Germany

Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )

MRD management in adults with acute lymphoblastic leukaemia

Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy

MRD management in adults with acute lymphoblastic leukaemia ( Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy )

Using CAR T cells for the treatment of acute lymphoblastic leukaemia

Prof Claudia Rossig - Universität Münster, Münster, Germany

Using CAR T cells for the treatment of acute lymphoblastic leukaemia ( Prof Claudia Rossig - Universität Münster, Münster, Germany )

Optimal use of tyrosine kinase inhibitors as a treatment for Philadelphia...

Prof Hervé Dombret, University Paris Diderot, Paris, France

Optimal use of tyrosine kinase inhibitors as a treatment for Philadelphia chromosome-positive acute lymphoblastic leukaemia ( Prof Hervé Dombret, University Paris Diderot, Paris, France )

Highlights from ICALL 2019

Prof Hervé Dombret - University Paris Diderot, Paris, France

Highlights from ICALL 2019 ( Prof Hervé Dombret - University Paris Diderot, Paris, France )

Precision diagnosis for tailored therapy in acute lymphoblastic leukaemia

Dr Jean-Pierre Bourquin - University Children’s Hospital, Zurich, Switzerland

Precision diagnosis for tailored therapy in acute lymphoblastic leukaemia ( Dr Jean-Pierre Bourquin - University Children’s Hospital, Zurich, Switzerland )

Integrating, balancing and disregarding risk factors in paediatric acute...

Prof Anthony Moorman - Newcastle University, Newcastle, UK

Integrating, balancing and disregarding risk factors in paediatric acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )

Managing metabolism and drug toxicity in acute lymphoblastic leukaemia

Dr Mary Relling - St Jude's Children's Research Hospital, Memphis, USA

Managing metabolism and drug toxicity in acute lymphoblastic leukaemia ( Dr Mary Relling - St Jude's Children's Research Hospital, Memphis, USA )

More from ecancer